SABATINI BRENT (SVP, Chief Accounting Officer) sold 2.5% of their position (1.83K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $13.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001628280-26-011331
Officer· SVP, Chief Accounting Officer
Since Feb 2026
+73.17K
Net shares
Net buyer
$13.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
75K acquired · 1.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
52.2%
2/22/2026
47.87K→72.87K
Common Stock
Direct
Shares
−1.83K
Price / share
$7.45
Trade value
$13.63K
% of position
2.5%
2/23/2026
72.87K→71.04K
Total
Net shares
+23.17K
Net value
-$13.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2026 | A · Award | +25K | — | — | 52.2% | 47.87K | 72.87K |
| Common Stock Direct | 2/23/2026 | S · Sale | −1.83K | $7.45 | $13.63K | 2.5% | 72.87K | 71.04K |
| Total | +23.17K | -$13.63K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
7.56
Held after
50K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 2/22/2026 | A · Award | +50K | 7.56 | — | 50K |